Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Short-term Investments (2016 - 2018)

Nephros has reported Short-term Investments over the past 5 years, most recently at $24000.0 for Q3 2018.

  • Quarterly results put Short-term Investments at $24000.0 for Q3 2018, up 20.0% from a year ago — trailing twelve months through Sep 2018 was $24000.0 (up 20.0% YoY), and the annual figure for FY2017 was $20000.0, down 25.93%.
  • Short-term Investments for Q3 2018 was $24000.0 at Nephros, down from $31000.0 in the prior quarter.
  • Over the last five years, Short-term Investments for NEPH hit a ceiling of $31000.0 in Q2 2018 and a floor of $15000.0 in Q2 2017.
  • Median Short-term Investments over the past 3 years was $22000.0 (2016), compared with a mean of $23090.9.
  • Biggest five-year swings in Short-term Investments: plummeted 42.31% in 2017 and later surged 106.67% in 2018.
  • Nephros' Short-term Investments stood at $27000.0 in 2016, then dropped by 25.93% to $20000.0 in 2017, then increased by 20.0% to $24000.0 in 2018.
  • The last three reported values for Short-term Investments were $24000.0 (Q3 2018), $31000.0 (Q2 2018), and $26000.0 (Q1 2018) per Business Quant data.